{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:53:59Z","timestamp":1792371239635,"version":"4.4.0"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:p>Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome is a monogenic disorder associated with autoimmune destruction of both endocrine and nonendocrine tissues. The classic triad includes candidiasis, hypoparathyroidism, and Addison disease. Up to 25% of patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome also have gastrointestinal manifestations, which can have an impact on the management of other aspects of the disease. The management of the case discussed was challenging because of the complex interplay between the manifestations and treatment of his hypoparathyroidism, Addison disease, and autoimmune enteropathy. Attempts at management of hypocalcemia were largely unsuccessful until the introduction of immunosuppressive therapy for autoimmune enteropathy. This case supports early consideration of immunosuppression in this condition.<\/jats:p>","DOI":"10.1542\/peds.2013-3308","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T02:42:23Z","timestamp":1416278543000},"page":"e1720-e1726","source":"Crossref","is-referenced-by-count":8,"title":["Recalcitrant Hypocalcaemia in Autoimmune Enteropathy"],"prefix":"10.1542","volume":"134","author":[{"given":"Myfanwy","family":"Geyer","sequence":"first","affiliation":[{"name":"Departments of Endocrinology and Diabetes,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fairchild","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Diabetes,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moore","sequence":"additional","affiliation":[{"name":"Gastroenterology,"},{"name":"University of Adelaide, Adelaide, South Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Moore","sequence":"additional","affiliation":[{"name":"Surgical Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Henning","sequence":"additional","affiliation":[{"name":"Nephrology, Women\u2019s and Children\u2019s Hospital, Adelaide, South Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Tham","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Diabetes,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"issue":"8","key":"2021120906244646800_B1","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/jc.2005-2611","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.","volume":"91","author":"Perheentupa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2021120906244646800_B2","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.lpm.2012.10.005","article-title":"Polyglandular autoimmune syndrome type I.","volume":"41","author":"Proust-Lemoine","year":"2012","journal-title":"Presse Med"},{"issue":"4","key":"2021120906244646800_B3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jc.2011-2461","article-title":"Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.","volume":"97","author":"Meloni","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021120906244646800_B4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","article-title":"Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.","volume":"265","author":"Husebye","year":"2009","journal-title":"J Intern Med"},{"issue":"1","key":"2021120906244646800_B5","first-page":"9","article-title":"Update on autoimmune polyendocrine syndromes (APS).","volume":"74","author":"Betterle","year":"2003","journal-title":"Acta Biomed"},{"issue":"5","key":"2021120906244646800_B6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2796.2009.02094.x","article-title":"Introduction: Autoimmune polyendocrine syndrome type 1 (APS-1): a rare monogenic disorder as a model to improve understanding of tolerance and autoimmunity.","volume":"265","author":"K\u00e4mpe","year":"2009","journal-title":"J Intern Med"},{"issue":"11","key":"2021120906244646800_B7","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1210\/jc.2008-0935","article-title":"Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.","volume":"93","author":"Meloni","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120906244646800_B8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MCG.0b013e31827356e1","article-title":"Gastrointestinal manifestations in APECED syndrome.","volume":"47","author":"Kluger","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"2021120906244646800_B9","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0706487","article-title":"Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.","volume":"358","author":"Alimohammadi","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120906244646800_B10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1073\/pnas.0610070104","article-title":"Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.","volume":"104","author":"Bensing","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2021120906244646800_B11","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1210\/jcem.87.6.8564","article-title":"AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype.","volume":"87","author":"Halonen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120906244646800_B12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/jc.2012-2734","article-title":"Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1.","volume":"98","author":"Scarpa","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2021120906244646800_B13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1056\/NEJM197709222971204","article-title":"Autoimmune vitiligo: detection of antibodies to melanin-producing cells.","volume":"297","author":"Hertz","year":"1977","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120906244646800_B14","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1210\/jc.2011-2044","article-title":"Loss of enteroendocrine cells in autoimmune-polyendocrine-candidiasis-ectodermal-dystrophy (APECED) syndrome with gastrointestinal dysfunction.","volume":"97","author":"Posovszky","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2021120906244646800_B15","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1210\/jc.2005-2506","article-title":"Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption.","volume":"91","author":"Oliva-Hemker","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2021120906244646800_B16","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1210\/jc.2003-030089","article-title":"Reversible metaphyseal dysplasia, a novel bone phenotype, in two unrelated children with autoimmunepolyendocrinopathy-candidiasis-ectodermal dystrophy: clinical and molecular studies.","volume":"88","author":"Harris","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021120906244646800_B17"},{"issue":"4","key":"2021120906244646800_B18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/jcem.83.4.4682","article-title":"Clinical review 93: Autoimmune polyglandular syndrome type 1.","volume":"83","author":"Betterle","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"9178","key":"2021120906244646800_B19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(99)01989-3","article-title":"Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1.","volume":"354","author":"Ekwall","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"2021120906244646800_B20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10408363.2010.536429","article-title":"Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors.","volume":"47","author":"Fleet","year":"2010","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"2021120906244646800_B21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0115426507022003286","article-title":"Calcium supplementation in clinical practice: a review of forms, doses, and indications.","volume":"22","author":"Straub","year":"2007","journal-title":"Nutr Clin Pract"},{"issue":"6","key":"2021120906244646800_B22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00002018-199921060-00004","article-title":"Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.","volume":"21","author":"Olyaei","year":"1999","journal-title":"Drug Saf"},{"issue":"1","key":"2021120906244646800_B23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1210\/jc.2005-1538","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity.","volume":"91","author":"Ulinski","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021120906244646800_B24","first-page":"844","article-title":"Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy.","volume":"84","author":"Ward","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021120906244646800_B25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000297714","article-title":"Autoimmune polyendocrine syndrome type 1 in north-western France: AIRE gene mutation specificities and severe forms needing immunosuppressive therapies.","volume":"74","author":"Proust-Lemoine","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"2021120906244646800_B26"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/6\/e1720\/1093269\/peds_2013-3308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/6\/e1720\/1093269\/peds_2013-3308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:46:09Z","timestamp":1639097169000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/6\/e1720\/33136\/Recalcitrant-Hypocalcaemia-in-Autoimmune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-3308","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}